Cargando…
A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report
The present case report describes a 46-year-old female patient diagnosed with M4 acute myeloid leukemia (AML), accompanied with a t(1;9)(p22;q34) chromosomal abnormality. Transcriptome sequencing identified a DEK proto-oncogene (DEK)/nucleoporin (NUP)214 fusion gene, which results from the t(6;9)(p2...
Autores principales: | Hao, Qishan, Zhang, Qi, Li, Chengwen, Wei, Shuning, Li, Qinghua, Song, Yang, Mi, Yingchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754883/ https://www.ncbi.nlm.nih.gov/pubmed/29344131 http://dx.doi.org/10.3892/ol.2017.7133 |
Ejemplares similares
-
Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromized mouse model
por: Qin, Haiyan, et al.
Publicado: (2016) -
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
por: Sandén, Carl, et al.
Publicado: (2013) -
A Rare Case of Acute Myeloid Leukemia With SET-NUP214 Fusion and Massive Hyperdiploidy
por: Jeong, In Hwa, et al.
Publicado: (2019) -
NUP214 fusion genes in acute leukemia (Review)
por: ZHOU, MIN-HANG, et al.
Publicado: (2014) -
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy
por: Day, James W, et al.
Publicado: (2022)